NathanC. Nitric oxide as a secretory product of mammalian cells. FASEB J1992; 6:3051–64.
2.
GreenLCRuiz de LuzuriagaKWagnerDA. Nitrate biosynthesis in man. Proc Natl Acad Sci USA1981; 78:7764–8.
3.
GreenLCTannenbaumSRGoldmanP. Nitrate synthesis in the germfree and conventional rat. Science1981; 212:56–68.
4.
WagnerDAYoungVRTannenbaumSR. Mammalian nitrate biosynthesis: Incorporation of 15NH3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA1983; 80:4518–21.
5.
StuehrDJMarlettaMA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA1985; 82:7738–42.
6.
IyngarRStuehrDJMarlettaMA. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci USA1987; 84:6369–73.
7.
MiwaMStuehrDJMarlettaMA. Nitrosation of amines by stimulated macrophages. Carcinogenesis1987; 8:955–8.
8.
HibbsJB. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: a molecular mechanism regulating cellular proliferation that targets intracellular iron. In: Nitric oxide from L-arginine: a bioregulatory system. eds. MoncadaSHiggsEA. Amsterdam: Elsevier, 1990; 189–223.
9.
HibbsJBJrTaintorRRVavrinZ. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science1987; 235:473–6.
10.
StuehrDJMarlettaMA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Research1987; 47:5590–4.
11.
FurchgottRFZawadskiJV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature1980; 288:373–6.
12.
ArnoldWPMittalCKKatsukiS. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA1977; 74:3203–7.
13.
IgnarroLJByrnsREWoodsKS. Biochemical and pharmacological properties of endothelium derived relaxing factor and its similarity to nitric oxide radical. In: Vascular smooth muscle, peptides, autonomic nerves, and endothelium. ed. VanhouttePM. New York: Raven Press, 1988; 427–36.
14.
PalmerRMFerrigeAGMoncadaS. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature1987; 327:524–6.
15.
IgnarroLJBugaCMWoodKS. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA1987; 84:9265–9.
SchmidtHHNauHWittfohtW. Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol1988; 154:213–6.
18.
PalmerRMJReesDDAshtonDSMoncadaS. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun1988; 153:1251–6.
19.
FerrendelliJA. Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids. J Neurochem1974; 22:535–40.
20.
MikiNKawabeYKuriyamaK. Activation of cerebral guanylate cyclase by nitric oxide. Biochem Biophys Res Commun1977; 75:851–6.
21.
DeguchiTYoshiokaM. L-arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J Biol Chem1982; 257:10147–52.
22.
GarthwaiteJCharlesSLChess-WilliamsR. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature1988;385–8.
23.
KnowlesRGPalaciosM. Formation of nitric oxide from L-arginine in the central nervous system. A transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA1989; 86:5159–62.
24.
Di RosaMRadomskiMCarnuccioRMoncadaS. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun1990; 172:1246–52.
25.
DingANathanCFGraycarJ. Macrophage deactivation factor and transforming growth factors -beta 1, -beta 2, and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by interferon gamma. J Immunol1990; 145:940–4.
26.
MoncadaS. The evolution of nitric oxide biology, invited lecture, Americam Heart Association, Anaheim, USA, 1991.
27.
IgnarroLJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann Rev Pharmacol Toxicol1990; 30:535–60.
28.
HibbsJB. Synthesis of nitric oxide from a guanidino nitrogen of L-arginine: a molecular mechanism that targets intracellular iron. In: Nitric oxide from L-arginine: a bioregulatory system. eds. MoncadaSHiggsEA. Amsterdam: Elsevier, 1990; 189–223.
29.
BeckmanJS. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA1990; 87:1620–4.
30.
BassengeEBusseR. Endothelial modulation of coronary tone. Prog Cardiovasc Dis1988; XXX No 5:349–80.
31.
ParkKHRubinLEGrossSSLeviR. Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites. Circ Res1992; 71:992–1001.
32.
HendersonAH. Endothelium in control. Br Heart J1991; 65:116–25.
33.
LampingKGDoleWP. Acute hypertension selectivity potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo. Circ Res1987; 61:904–13.
34.
PanzaJAQuyyumiAABrushJEJrEpsteinSE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med1990; 323:22–7.
35.
CalverA. Effect of local intra-arterial N-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertension1992; 10:1025–31.
36.
CoeneCHermanAGJordaensF. Endothelium-dependent relaxations in isolated arteries of control and hypercholesterolemic rabbits. Br J Pharmacol1985; 85:257.
37.
LeFroyDCCrakeTUrenNG. Effects of nitric oxide in the human coronary circulation. Circulation1992; 86(abstr.Suppl):118.
38.
BrutsaertDLMeulemansALSpidioKRSysSU. Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res1988; 62:358–66.
39.
ShahAM. Influence of endothelium-derived NO on myocardial contractile function. Int J Cardiol1995; 50:225–32.
40.
ShahAMGrocott-MasonRMPepperCB. The cardiac endothelium: cardioactive mediators. Prog Cardiovasc Dis1996; 39:263–84.
41.
BradyAJBWarrenJBPoole-WilsonPAHardingSE. Differential metabolism of nitrovasodilators by cardiac myocytes: sodium nitroprusside reduces myocyte contractility. Br J Pharmacol1992; 105:96P.
KellyRABalligandJ-L. Nitric oxide and cardiac function. Circ Res1996; 79:363–80.
44.
BradyAJBPoole-WilsonPA. Circulatory failure in septic shock. Br Heart J1993; 70:103–5.
45.
BradyAJBPoole-WilsonPAHardingSEWarrenJB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxaemia. Am J Physiol1992; 263:H1963–6.
46.
FinkelMSOddisCVJacobTD. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science1992; 257:387–9.
47.
SmithJAShahAMLewisMJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol (Lond)1991; 439:1–14.
48.
WrightCEReesDDMoncadaS. Protective and pathological role of nitric oxide in endotoxic shock. Cardiovascular Research1992; 26:48–57.
49.
PetrosABennettDVallanceP. Effect of nitric oxide synthesis inhibitors on hypotension in patients with septic shock. Lancet1991; 338:1557–8.
50.
MidgleySGrantISHaynesWG and WebbDJ. Nitric oxide in liver failure. Lancet1991; 338:1590.
51.
RobinsonNMKWestmoreKRMartinJF. INOS gene transcription during endotoxaemia. Biochem Biophys Res Comm1997; 231:211–6.
52.
de BelderAJRadomskiMWWhyHJ. NOS activities in human myocardium. Lancet1993; 341:84–5.
53.
HabibFMSpringallDRDaviesGJ. TNF and iNOS in dilated cardiomyopathy. Lancet1996; 347:1151–5.
54.
WidhirtSMSuzukiHDudekRR. INOS as a potential mediator of apoptosis after MI. Eur Heart J1996; 17(abstr.Suppl):105.